Search results for: Massachusetts General Hospital | Wyss Institute

Wyss Institute Search Site

Technologies 1

FeCILL: Targeted Treatment for Severe Fungal Infections
FeCILL is novel delivery vehicle for antifungal drugs that targets them right to the infection site and reduces harmful side effects in patients with severe fungal infections.

News 1

Multimedia 1

Video/Animation

FeCILL: Reimagining How We Treat the Sickest Patients
Opportunistic fungal infections usually only affect patients whose immune systems are compromised, but when they do, they are often deadly – the mortality rate for these infections can be as high as 25%. Existing antifungal treatments have high levels of toxicity, and can harm the patient more than they help. Researchers at the Wyss Institute...